| AJCC | American Joint Committee on Cancer |
| SNP | Single Nucleotide Polymorphism |
| BCG | Bacillus Calmette–Guérin |
| SLN | Sentinel lymph node |
| DFS | Disease free survival |
| HR | Hazard ratio |
| OS | Overall survival |
| IL | Interleukin |
| ICI | Immune Checkpoint Inhibitors |
| GM-CSF | Granulocyte-macrophage colony-stimulating factor |
| TLR | Toll-Like Receptor |
| MSLT-I | Multicenter Selective Lymphadectomy |
| MMAIT | Malignant Melanoma Active Immunotherapy Trial |
| TNF | Tumor necrosis factor |
| CCR5 | C-C chemokine receptor type 5 |
| CXCL12 | C-X-C motif chemokine 12 |
| NRAMP1 | natural resistance-associated macrophage protein 1 |
| SLC11A1 | solute carrier protein 11A1 |
| CD209 | Cluster of Differentiation 209 |
| DC-SIGN | Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin |
| BTNL2 | Butyrophilin Like 2 |
| PCA | Principal Component Analysis |
| DTH | Delayed Type Hypersensitivity |
| PPD | Purified Protein Derivative |
| VEGF | Vascular Endothelial Factor |
| pDC | Plasmacytoid Dendritic Cells |
| CT | Computed Tomography |
| MRI | Magnetic Resonance Imaging |
| ECOG | Eastern Cooperative Oncology Group |
| PBL | Peripheral Blood Leukocytes |
| IRB | Institutional Review Board |
| DTH | Delayed Type Hypersensitivity |
| MIP | Macrophage Inflammation Protein |
| TB | Tuberculosis |
| ECOG | Eastern Cooperative Oncology Group |
| CLND | Complete Lymph Node Dissection |